Amanda Bishop McFarland

Amanda Bishop McFarland is a Senior Consultant at ValSource Inc. since May 2015 and serves as Co-Lead of the Quality Risk Management Interest Group at PDA - Parenteral Drug Association since March 2017, focusing on advancing Quality Risk Management practices. Prior experience includes a role as Senior Continuous Process Improvement Analyst at Genzyme, where responsibility included the design and oversight of a global Quality Risk Management program. Earlier positions at Genzyme involved microbiology, emphasizing environmental monitoring and root cause analysis. Amanda also managed a 24-hour laboratory at EMSL Analytical, securing key accreditations. Educational qualifications include a Master of Science in Mycology and a Bachelor of Science in Entomology, both from the University of Florida.